Pfizer Inc (PFE)

40.08
-0.04(-0.10%)
  • Volume:
    11,253
  • Bid/Ask:
    40.08/40.16
  • Day's Range:
    40.02 - 40.24
Earnings results expected today

Pfizer will announce its quarterly financial results today. Traders should take this into account as the share price often fluctuates around this time period.

PFE Overview

Prev. Close
40.12
Day's Range
40.02-40.24
Revenue
-
Open
40.02
52 wk Range
39-53.4
EPS
-
Volume
11,253
Market Cap
225.16B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
27,836
P/E Ratio
8.18
Beta
-
1-Year Change
-17.62%
Shares Outstanding
5,613,314,537
Next Earnings Date
Jan 31, 2023
What is your sentiment on Pfizer?
or
Vote to see community's results!

Pfizer Inc News

  • Marketmind: Mind the gap
    • ByReuters-

    A look at the day ahead in European and global markets from Anshuman Daga An impressive 6% rally in global stocks this month, the first gain in January after three years, has got...

  • Marketmind: Fasten your seatbelts
    • ByReuters-

    By Stephen Culp (Reuters) - A look at the day ahead in markets from Stephen Culp, New York stock market reporter. Wall Street's downbeat start to an action-packed week has set a...

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035
  • WKN:852009

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.

Read More

Analyst Price Target

Average54.30 (+24.68% Upside)
High75.00
Low44.00
Price43.55
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralStrong SellNeutral
Technical IndicatorsStrong BuyBuySellStrong SellStrong Sell
SummaryStrong BuyBuyNeutralStrong SellSell
  • Project veritage video is going viral ,timber!
    1
    • This turdsucker is easy money short short and short again
      2
      • Pfizer is the best short stock ever. I always like to short this worthless stock.
        5
        • short this trash scam to the ground
          4
          • on the decline due to not telling about all the adverse reactions to shots. just general info
            2
            • Buy
              3
              • shorts are being sold
                0
                • Pfizer will turn to his previous of 30-35 monthly. Until another pandemic blow as the monkey pox did not had enough impact. Hope that AstraZeneca and Russian Sputnik do not have the same impact. Just saying...
                  2
                  • Pfizer is 100% manipulated by the CEO and other insiders. That's why its stock price will never go up.
                    2
                    • I wish it closes in green today
                      1
                  • AstraZeneca goes high everyday, but Pfizer keeps falling... that is why the billionaires are not interested in Pfizer.
                    0
                    • Astras doomed days are on tge horizon
                      0